Previous close | 0.0500 |
Open | 0.0200 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 7.50 |
Expiry date | 2024-05-17 |
Day's range | 0.0200 - 0.0200 |
Contract range | N/A |
Volume | |
Open interest | 224 |
Fate Therapeutics, Inc. (NASDAQ:FATE) Q1 2024 Earnings Call Transcript May 11, 2024 Fate Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Fate Therapeutics First Quarter 2024 Financial Results Conference Call [Operator Instructions]. This call is […]
Fate Therapeutics ( NASDAQ:FATE ) First Quarter 2024 Results Key Financial Results Net loss: US$48.0m (loss widened by...
Despite Revenue Growth, Losses Widen; Clinical Trials Progress in Autoimmune and Cancer Treatments